BIOTECH · Kura spins off $50M diabetes biotech with Lilly's backing
The new company, Caspian Therapeutics, is chasing a treatment that could change how diabetes progresses, not just manage blood sugar.
@thedailyfathom.bsky.socialExplore
@thedailyfathom.bsky.social